Clinical Trial Update: Safety Evaluation of Aline HA, an Implanted Cross-Linked HA Device [NA]

View source ↗

Summary

This completed trial provides safety results for Aline HA, an implanted cross-linked hyaluronic acid device, with results posted in December 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Disorders of Soft Tissue

Drugs mentioned

• Aline HA

Snippet

Sponsor: TauTona Group | Conditions: Disorder of Soft Tissue | NA | Status: COMPLETED | Results posted: 2014-12-17